Baxter BioPharm Solutions

Article

Sponsored Content

BioPharma Solutions, a business unit of Baxter, collaborates with pharmaceutical companies to provide contract manufacturing form/fill/finish for sterile injectables.

BioPharma Solutions, a business unit of Baxter, collaborates with pharmaceutical companies to provide contract manufacturing form/fill/finish for sterile injectables.  Our expertise includes oncology products, biologics, ADCs, and vaccines; and we offer a variety of sterile dosage forms, including prefilled syringes, liquid vials, lyophilized vials, cartridges, and cost-saving diluents for reconstitution.

Baxter BioPharm Solutions
One Baxter Parkway, Deerfield, IL 60015
biopharmasolutions@baxter.com  
tel. 224.948.3278
CPhI North America Booth #1445

Recent Videos
Roger Viney, PhD, chief commercial officer for ICE Pharma
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Endo Recalls Adrenalin Chloride Solution

Susan Haigney
December 23rd 2024
Article

The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an unapproved drug.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Site Logo

Lonza's Commitment to the Future (Dec 2024)

Lonza
December 20th 2024
Article

Meeta B. Kratz (Global Vice President, Product Management & Marketing, Lonza Capsule and Health Ingredients) talks about Lonza's future and how that works in tandem to meet client needs.

Site Logo

Development Process for Transforming a Liquid Protein Solution into a Solid Oral Dosage Form

Bend BioScience
December 20th 2024
Article

A case study in converting a solution formulation of a protein into an oral solid dosage form utilizing a fluid bed granulation process and some of the complexities involved.